Yesterday's announced financings: June 1

Here’s your roundup of yesterday's announced equity financings, courtesy of PrivatePlacements.com: the only database that tracks every financing, every day.

1. Bravo Mining Corp. (TSX-V: BRVO)

• Gross Proceeds: $20 million
• Sector: Precious metals
• Units issued: 4.91 million
• Type: Common shares
• Price: $3.50
• Warrants: None
• Agents: Canaccord Genuity    
• Use of Proceeds: Not stated

Company breakdown:

• Precious metals miner focused on the Luanga project in Brazil
• Recently drilled 71.4 metres of 1.94 g/t PGM+Au
• Shares have been climbing since December

2. Surge Battery Metals Inc. (TSX-V: NILI)

• Gross Proceeds: $7.16 million
• Sector: Battery metals
• Units issued: 17.9 million
• Type: Special units
• Price: $0.40
• Warrants: Full; $0.55; Three years
• Agents: Non-brokered      
• Use of Proceeds: Ongoing exploration

Company breakdown:

• Lithium and nickel junior with projects in Nevada and BC
• Its Nevada North project has 8 drill holes with average grade of 3200 ppm

3. Stallion Discoveries Corp. (TSX-V: STUD)

• Gross Proceeds: $4 million
• Sector: Metals
• Units issued: 5.41 million
• Type: Flow-through units
• Price: $0.33
• Warrants: Half; $0.45; Two years
• Agents: Non-brokered   
• Use of Proceeds: Ongoing exploration

Company breakdown:

• Uranium and precious metals company focused on projects in Athabasca Basin, Idaho, and Nevada
• Shares rose after it acquired its claims in Athabasca, pivoting to uranium

4. SPC Nickel Corp. (TSX-V: SPC)

• Gross Proceeds: $3 million
• Sector: Nickel
• Units issued: 33.33 million
• Type: Common shares; Flow-through shares
• Price: $0.09; $0.105
• Warrants: None
• Agents: Non-brokered        
• Use of Proceeds: Ongoing exploration

Company breakdown:

• Nickel, PGM, and copper junior focused on projects in Ontario
• Recently drilled 20 metres of 1.71% nickel at its West Graham project

5. Hemostemix Inc. (TSX-V: HEM)

• Gross Proceeds: $1.2 million
• Sector: Stem cell therapy
• Units issued: 10 million
• Type: Special units
• Price: $0.12
• Warrants: Half; $0.25; Two years
• Agents: Non-brokered        
• Use of Proceeds: Not stated

Company breakdown:

• Stem cell therapeutics company developing treatments for ischemic diseases